A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease
Journal of Ocular Pharmacology and Therapeutics, Ahead of Print. (Source: Journal of Ocular Pharmacology and Therapeutics)
Source: Journal of Ocular Pharmacology and Therapeutics - January 15, 2021 Category: Opthalmology Authors: David Clark John Sheppard Todd C. Brady Source Type: research

The Effects of Antiglaucoma Ophthalmic Solutions on the Cornea Revealed by a Corneal Electrical Resistance Device
Journal of Ocular Pharmacology and Therapeutics, Ahead of Print. (Source: Journal of Ocular Pharmacology and Therapeutics)
Source: Journal of Ocular Pharmacology and Therapeutics - January 13, 2021 Category: Opthalmology Authors: Nobuo Takeda Masamichi Fukuda Hiroshi Sasaki Kazuhisa Sugiyama Source Type: research

Intraocular Injection of HyStem Hydrogel Is Tolerated Well in the Rabbit Eye
Journal of Ocular Pharmacology and Therapeutics,Volume 37, Issue 1, Page 60-71, January/February 2021. (Source: Journal of Ocular Pharmacology and Therapeutics)
Source: Journal of Ocular Pharmacology and Therapeutics - January 11, 2021 Category: Opthalmology Authors: Randolph D. Glickman Michael Onorato Maria M. Campos Michael P. O'Boyle Ratnesh K. Singh Thomas I. Zarembinski Francois Binette Igor O. Nasonkin Source Type: research

A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease
Journal of Ocular Pharmacology and Therapeutics,Volume 37, Issue 1, Page 4-11, January/February 2021. (Source: Journal of Ocular Pharmacology and Therapeutics)
Source: Journal of Ocular Pharmacology and Therapeutics - January 11, 2021 Category: Opthalmology Authors: Jeongah Shin Chang Rae Rho Joon Young Hyon Tae-Young Chung Kyung Chul Yoon Choun-Ki Joo Source Type: research

Eyes on New Product Development
Journal of Ocular Pharmacology and Therapeutics,Volume 37, Issue 1, Page 1-3, January/February 2021. (Source: Journal of Ocular Pharmacology and Therapeutics)
Source: Journal of Ocular Pharmacology and Therapeutics - January 11, 2021 Category: Opthalmology Authors: Gary D. Novack Source Type: research